Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
449.02
6.29 (1.42%)
At close: Aug 15, 2025, 3:59 PM
448.00
-0.23%
After-hours: Aug 15, 2025, 05:30 PM EDT
Alnylam Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.11B | 1.02B | 966.43M | 1.1B | 968.49M | 681.88M | 812.69M | 1.03B | 657.8M | 672.25M | 866.39M | 1.07B | 575.56M | 534.08M | 819.98M | 1.09B | 745.77M | 379.54M |
Short-Term Investments | 1.74B | 1.61B | 1.73B | 1.68B | 1.66B | 1.69B | 1.63B | 1.37B | 1.4B | 1.4B | 1.33B | 1.19B | 1.54B | 1.71B | 1.62B | 1.23B | 1.15B | 1.33B |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 125.77M | 142.41M | 133.9M | 146.21M | 121.32M | 116.85M | 111.29M | 124.55M | 142.07M | 112.84M | 115.48M | 110.78M | 126.66M | 110.71M | 101.09M | 76.16M | 75.48M | 583.4M |
Receivables | 567.11M | 418.04M | 405.31M | 353.85M | 309.48M | 321.38M | 327.79M | 325.44M | 220.63M | 219.43M | 237.96M | 184.51M | 142.27M | 156.53M | 198.57M | 141.06M | 646.59M | 110.63M |
Inventory | 71.69M | 65.58M | 78.51M | 75.99M | 83.98M | 93.99M | 89.15M | 95.77M | 100.45M | 131.88M | 128.96M | 115.49M | 88.98M | 78.52M | 86.36M | 97.9M | 84.36M | 73.94M |
Other Current Assets | 147.31M | 152.42M | 116.96M | 145.35M | 154.75M | 201.96M | 126.38M | 157.96M | 145.45M | 119.03M | 132.92M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 3.64B | 3.27B | 3.3B | 3.36B | 3.17B | 2.99B | 2.98B | 2.99B | 2.52B | 2.54B | 2.69B | 2.69B | 2.47B | 2.59B | 2.81B | 2.68B | 2.73B | 1.97B |
Property-Plant & Equipment | 692.19M | 695.92M | 693.93M | 703.4M | 715.46M | 718.93M | 725.79M | 729.08M | 736.27M | 738.08M | 738.63M | 733.62M | 732.12M | 733.16M | 733.63M | 720.79M | 708.79M | 701.78M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 922.32M | 945.55M | 944.7M | 849.62M | 836.78M | 835.78M | 847.18M | 853.62M | 878.35M | 850.92M | 854.11M | 844.41M | 858.78M | 843.87M | 834.73M | 796.95M | 784.27M | 1.29B |
Total Assets | 4.57B | 4.21B | 4.24B | 4.21B | 4.01B | 3.82B | 3.83B | 3.84B | 3.4B | 3.39B | 3.55B | 3.54B | 3.33B | 3.43B | 3.64B | 3.47B | 3.51B | 3.26B |
Account Payables | 102.39M | 97.4M | 88.42M | 70.81M | 73.98M | 78.15M | 55.52M | 73.84M | 59.75M | 62.24M | 98.09M | 40.57M | 52.42M | 54.92M | 73.43M | 40.05M | 53.08M | 45.38M |
Deferred Revenue | 15.08M | 28.16M | 55.48M | 71.03M | 69.01M | 76.85M | 102.75M | 77.14M | 54.64M | 35.79M | 42.1M | 144.21M | 114.29M | 131.84M | 149.48M | 115.04M | 98.14M | 116.34M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 218.31M | 199.89M | 327.42M | 90.52M | 61.96M | 46.17M | 177.16M | 44.2M | 33.65M | 23.71M | 170.98M | 35.85M | 28.5M | 21.98M | 130.66M | 26.38M | 22.88M | 13.66M |
Total Current Liabilities | 1.3B | 1.08B | 1.19B | 1.22B | 1.06B | 941.71M | 967.79M | 949.78M | 788.64M | 673.39M | 767.91M | 772.79M | 657.68M | 605.96M | 695.71M | 610.66M | 554.65M | 494.82M |
Long-Term Debt | 1.03B | 1.03B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 677.72M | 676.71M | 675.7M | 433.8M | 433.15M | 191.59M |
Other Long-Term Liabilities | 1.76B | 1.77B | 1.73B | 1.69B | 1.69B | 1.66B | 1.63B | 1.59B | 1.56B | 1.51B | 1.46B | 1.41B | 1.37B | 1.31B | 1.25B | 1.21B | 1.18B | 1.15B |
Total Long-Term Liabilities | 3.01B | 3.02B | 2.99B | 2.95B | 2.96B | 3.1B | 3.08B | 3.06B | 3.02B | 2.98B | 2.94B | 2.83B | 2.5B | 2.43B | 2.36B | 2.11B | 2.1B | 1.83B |
Total Liabilities | 4.32B | 4.1B | 4.17B | 4.17B | 4.01B | 4.04B | 4.05B | 4B | 3.81B | 3.65B | 3.7B | 3.6B | 3.15B | 3.03B | 3.06B | 2.72B | 2.66B | 2.33B |
Total Debt | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.31B | 1.31B | 1.31B | 1.32B | 1.32B | 1.32B | 990.98M | 995.39M | 997.59M | 760.44M | 761.07M | 518.52M |
Common Stock | 1.31M | 1.3M | 1.29M | 1.29M | 1.28M | 1.26M | 1.26M | 1.25M | 1.25M | 1.24M | 1.24M | 1.23M | 1.21M | 1.21M | 1.2M | 1.2M | 1.19M | 1.17M |
Retained Earnings | -7.41B | -7.35B | -7.29B | -7.2B | -7.09B | -7.08B | -7.01B | -6.87B | -7.02B | -6.74B | -6.57B | -6.36B | -5.96B | -5.68B | -5.44B | -5.18B | -4.98B | -4.79B |
Comprehensive Income | -29.95M | -37.52M | -34.52M | -24.83M | -34.64M | -26.99M | -23.38M | -32.34M | -37.08M | -39.12M | -44.65M | -43.78M | -42.22M | -38.06M | -33.26M | -34.23M | -36.08M | -36.72M |
Shareholders Equity | 250.59M | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M | -220.64M | -165.87M | -408.13M | -259.24M | -158.22M | -67.64M | 176.04M | 401.17M | 588.2M | 755.89M | 853.36M | 926.19M |
Total Investments | 1.74B | 1.61B | 1.73B | 1.68B | 1.66B | 1.69B | 1.63B | 1.37B | 1.4B | 1.4B | 1.33B | 1.19B | 1.54B | 1.71B | 1.62B | 1.23B | 1.15B | 1.33B |